Cargando…
Use of FLT3 inhibitors in acute myeloid leukemia remission induction or salvage therapy: systematic review and meta-analysis
BACKGROUND: Previous studies showed that FLT3 inhibitors played an important role in acute myeloid leukemia (AML) therapy. However, discrepancies remain regarding the association between FLT3 inhibitors use and prognosis of AML patients in clinical trials. AIM: The aim of this study was to evaluate...
Autores principales: | Yang, Minglei, Zhao, Jian, Liu, Tielong, Yang, Xinghai, Wei, Haifeng, Xu, Wei, Xiao, Jianru |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6097505/ https://www.ncbi.nlm.nih.gov/pubmed/30147364 http://dx.doi.org/10.2147/CMAR.S166387 |
Ejemplares similares
-
FLT3 inhibitors in acute myeloid leukemia
por: Wu, Mei, et al.
Publicado: (2018) -
Clinical use of FLT3 inhibitors in acute myeloid leukemia
por: Sutamtewagul, Grerk, et al.
Publicado: (2018) -
FLT3 inhibitors: clinical potential in acute myeloid leukemia
por: Hospital, Marie-Anne, et al.
Publicado: (2017) -
Developments and challenges of FLT3 inhibitors in acute myeloid leukemia
por: Ge, Shuai-Shuai, et al.
Publicado: (2022) -
Autophagy activation mediates resistance to FLT3 inhibitors in acute myeloid leukemia with FLT3-ITD mutation
por: Xu, Dan, et al.
Publicado: (2022)